Design Therapeutics (DSGN) Change in Cash (2020 - 2026)

Design Therapeutics has reported Change in Cash for 7 years, with the latest figure at $137000.0 in Q2 2026.

• Change in Cash for Q2 2026 came in at $137000.0, down 97.73% year-over-year; the trailing twelve-month figure through Jun 2026 was -$6.8 million (up 73.86% YoY), and the FY2025 annual result was -$5.7 million, down 518.71% from the prior year.
• Change in Cash improved to $137000.0 in Q2 2026, from -$4.1 million in the prior quarter.
• Over five years, Change in Cash peaked at $16.3 million in Q2 2024 and troughed at -$167.7 million in Q2 2022.
• A 5-year average of -$15.9 million and a median of -$4.4 million in 2025 frame the typical range for Change in Cash.
• The largest YoY upside for Change in Cash was 1111.29% in 2024 against a maximum downside of 2163.22% in 2024.
• A 5-year view of Change in Cash shows it stood at -$16.0 million in 2022, then surged by 57.91% to -$6.7 million in 2023, then dropped by 15.17% to -$7.8 million in 2024, then jumped by 122.77% to $1.8 million in 2025, then sank by 92.25% to $137000.0 in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were $137000.0 in Q2 2026, -$4.1 million in Q1 2026, and $1.8 million in Q4 2025.